Protagonist Therapeutics, Inc (PTGX) › RevenueProtagonist Therapeutics, Inc (PTGX) — RevenueAnnual figures by period end, from SEC filings.2017-12-31: $20.06M2018-12-31: $30.93M2019-12-31: $231.0K2020-12-31: $28.63M2021-12-31: $27.36M2022-12-31: $26.58M2023-12-31: $60.00M2024-12-31: $434.43M2025-12-31: $46.02M$46.02M2017-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$46.02M-89.4%2026-02-25From 2025-01-012024-12-31$434.43M+624.1%2026-02-25From 2024-01-012023-12-31$60.00M+125.7%2026-02-25From 2023-01-012022-12-31$26.58M-2.8%2025-02-21From 2022-01-012021-12-31$27.36M-4.4%2024-02-27From 2021-01-012020-12-31$28.63M+12293.1%2023-03-15From 2020-01-012019-12-31$231.0K-99.3%2022-02-28From 2019-01-012018-12-31$30.93M+54.1%2019-03-12From 2018-01-012017-12-31$20.06M—2019-03-12From 2017-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)